Y Intercept (Hong Kong) LTD Amicus Therapeutics, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 986,779 shares of FOLD stock, worth $6.9 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
986,779
Previous 21,451
4500.15%
Holding current value
$6.9 Million
Previous $175,000
3130.86%
% of portfolio
0.15%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding FOLD
# of Institutions
307Shares Held
321MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$204 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$170 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$150 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$143 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.96B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...